Sable Offshore Corp

SOC

Market cap $893M

NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Sable Offshore Corp (NYSE: SOC) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.

The most oversold stocks in the energy sector presents an opportunity to buy into undervalued companies.

Sable Offshore Corp (NYSE:SOC) shares are trading higher by over 40% on Wednesday as traders digest the company's common stock and financing update.

HOUSTON--(BUSINESS WIRE)--Sable Offshore Corp. Prices Offerings of Common Stock and Convertible Senior Notes.

HOUSTON--(BUSINESS WIRE)--Sable Offshore Corp. Announces Proposed Offerings of Common Stock and Convertible Senior Notes.

ALLENTOWN, Pa., June 24, 2026 (GLOBE NEWSWIRE) -- CAI, a global services firm, was awarded a statewide contract with the Virginia Information Technologies Agency (VITA) to provide Security Operations Center (SOC) services to local government entities across the Commonwealth.

WILMINGTON, Del., June 23, 2026 (GLOBE NEWSWIRE) -- Quavo, Inc. ("Quavo"), the leading AI disputes technology partner and strategic advisor for financial institutions and technology companies, today announced the completion of its first System and Organization Controls (SOC) 1 Type 1 examination.

NEW YORK--(BUSINESS WIRE)--Hack The Box (HTB), the global leader in AI cybersecurity readiness, today announced new capabilities to help security leaders gain greater visibility into skills, performance and operational readiness. As AI transforms cyberattacks and cybersecurity operations, HTB is expanding its cyber readiness platform to help organizations identify gaps, evaluate team performance and strengthen organizational resilience. By combining hands-on Security Operations Center (SOC) tra.

HOUSTON--(BUSINESS WIRE)--Sable Offshore Corp. Enters Into Senior Secured Term Loan Amendment and Limited Waiver Under the PSA.

MANCHESTER, United Kingdom and OSAKA, Japan, June 18, 2026 (GLOBE NEWSWIRE) -- F2G Ltd and Shionogi & Co., Ltd (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D) (“Shionogi”) today announced positive topline results from the global Phase 3 OASIS study (NCT05101187), comparing the investigational oral antifungal drug olorofim versus AmBisome® (liposomal amphotericin B for injection) followed by standard of care (SOC) in patients with invasive aspergillosis whose infection is either refractory to or unsuitable for azole therapy.